A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -91.29% this year. Over the last six months, there has been a stronger performance of -28.55%. The price of HSDT fallen by 43.42% during the last 30 days period. For the last 5-days stocks have improved 45.88%.
The stock market performance of Helius Medical Technologies Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $9.50 on 02/06/24, while the lowest price during the same time frame was $0.37, recorded on 10/15/24.
52-week price history of HSDT Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Helius Medical Technologies Inc’s current trading price is -92.63% away from its 52-week high, while its distance from the 52-week low is 87.72%. The stock’s price range over this timeframe has been between $0.37 and $9.50. The shares of the Healthcare sector company recorded a trading volume of approximately 0.62 million for the day, which was comparatively lower than the average daily volume of 2.38 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Helius Medical Technologies Inc (HSDT) has experienced a quarterly rise of 3.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.26M and boasts a workforce of 22 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6334, with a change in price of +0.0302. Similarly, Helius Medical Technologies Inc recorded 1,625,222 in trading volume during the last 100 days, posting a change of +4.51%.
HSDT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for HSDT stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
HSDT Stock Stochastic Average
Helius Medical Technologies Inc’s raw stochastic average for the past 50 days is currently at 27.55%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 26.58%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 40.60% and 49.19%, respectively.
